When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1537-2995|55|6pt2|1555-1562

ISSN： 0041-1132

Source： TRANSFUSION, Vol.55, Iss.6pt2, 2015-06, pp. : 1555-1562

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal antibody therapy for classical Hodgkin lymphoma

By Paszkiewicz-Kozik Ewa   Walewski Jan  

Clinical Investigation, Vol. 3, Iss. 9, 2013-09 ,pp. : 899-910

Future Science

Access to resources Recommend Favorite

When to consider transfusion therapy for patients with non‐transfusion‐dependent thalassaemia

By  

VOX SANGUINIS, Vol. 108, Iss. 1, 2015-01 ,pp. : 1-10

John Wiley & Sons Inc

Access to resources Recommend Favorite

INFUSION THERAPY AND TRANSFUSION MEDICINE: Quo vadis?

By  

Transfusion Medicine and Hemotherapy, Vol. 28, Iss. 1, 2001-02 ,pp. : 6-7

Karger

Access to resources Recommend Favorite

Ein neuer Name, ein neues Profil – INFUSION THERAPY AND TRANSFUSION MEDICINE wird zu TRANSFUSION MEDICINE AND HEMOTHERAPY

By  

Transfusion Medicine and Hemotherapy, Vol. 30, Iss. 1, 2003-02 ,pp. : 7-

Karger

Access to resources Recommend Favorite

Considerations for pre‐transfusion immunohaematology testing in patients receiving the anti‐CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma

By  

INTERNAL MEDICINE JOURNAL, Vol. 48, Iss. 2, 2018-02 ,pp. : 210-220

John Wiley & Sons Inc

Access to resources Recommend Favorite